• Encompass Health Q2 2026 net operating revenue rose 9.6% to USD 1.6 billion; income from continuing operations per diluted share increased 10.7% to USD 1.55.
• Adjusted EBITDA climbed 9.2% to USD 348 million; cash flows from operating activities increased 4.6% to USD 282.6 million.
• Discharges grew 5.6% to 68,895; net patient revenue per discharge increased 3.9% to USD 22,521.
• Mark Tarr said three hospitals totaling 139 beds opened in the first half; five more are expected before year-end.
• Full-year 2026 guidance was raised, with net operating revenue seen at USD 6.41 billion to USD 6.49 billion; board lifted share repurchase authorization to USD 1 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.